Stocks Health care CRON
NASDAQ · Health careCronos Group Inc. (CRON)
Cronos Group Inc. brought in $271.9M of revenue over the twelve months to September 30, 2026, up 54.3% from a year earlier. Net income was $57.8M, a net margin of 21.3%. Operating cash flow minus capital spending left $149K of free cash flow in fiscal 2025. At September 30, 2026 it held $411.2M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 5, 2026.
Key facts about Cronos Group Inc.
- Net worth
- Cronos Group Inc. has a market value (market cap) of $1.3B at the latest share price, and shareholders' equity of $1.1B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $193.4M (+19.5% year on year), with a net loss of $9.4M. Over the 12 months to September 30, 2026: revenue $271.9M, net income $57.8M.
- Cash flow
- In fiscal 2025 operations brought in $25.9M of cash; after $25.7M of capital spending, free cash flow was $149K.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 5, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Cronos Group Inc.'s next report is expected around February 25, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Cronos Group Inc. does
Cronos Group Inc. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on NASDAQ under the ticker CRON.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $193.4M | -$9.4M | -$0.02 | $149K |
| 2024 | $161.8M | $41.1M | $0.11 | $6.4M |
| 2023 | $120.3M | -$74M | -$0.19 | -$45.3M |
| 2022 | $109.3M | -$168.7M | -$0.45 | -$92.4M |
| 2021 | $79.6M | -$396.1M | -$1.07 | -$164.8M |
| 2020 | $54.4M | -$73.1M | -$0.21 | -$176.3M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where CRON ranks in Health care
Latest SEC filings
What Cronos Group Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 5, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 72% to $83.9M versus the same quarter last year; diluted EPS $0.04 versus $0.07.
- November 5, 2026
- October 15, 2026
- September 11, 2026
- August 7, 2026Shareholder vote results 8-K/A
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 60% to $70.6M versus the same quarter last year; diluted EPS $0.09 versus -$0.10.
- August 6, 2026
- June 22, 2026
- May 29, 2026
- May 11, 2026Quarterly report 10-Q · period to March 31, 2026Revenue rose 41% to $59M versus the same quarter last year; diluted EPS $0.04 versus $0.02.
What is CRON worth? A DCF from its reported cash flow
Insider trades
What the people running Cronos Group Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| May 12, 2026 | Buggy ShannonSee Remarks | Exercised options | 20,622 | - |
| May 12, 2026 | Buggy ShannonSee Remarks | Shares withheld for tax | 9,179 | $25.2K |
| May 12, 2026 | Doucet Terrence Gregory JosephSee Remarks | Exercised options | 10,597 | - |
| May 12, 2026 | Doucet Terrence Gregory JosephSee Remarks | Shares withheld for tax | 5,199 | $19.5K |
| May 12, 2026 | Wagner AdamSee remarks | Exercised options | 10,367 | - |
| May 12, 2026 | Kenost Jared MatthewSee Remarks | Exercised options | 9,412 | - |
| May 12, 2026 | Kenost Jared MatthewSee Remarks | Shares withheld for tax | 3,701 | $10.2K |
| May 10, 2026 | Weigensberg AryeSee Remarks | Exercised options | 3,118 | - |
Who owns CRON
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
Largest institutional holders
Insiders
8 insiders reported holding 14,703,719 shares in total, about $50.1M at the last price.
| Holder | Shares |
|---|---|
| Gorenstein Michael RyanSee remarks below, Director | 13,213,017 |
| Jacobson Jeffrey DavidChief Growth Officer | 484,681 |
| Shlimak AnnaSee Remarks | 358,595 |
| Weigensberg AryeSee Remarks | 211,555 |
| Buggy ShannonSee Remarks | 178,322 |
| Doucet Terrence Gregory JosephSee Remarks | 110,588 |
| Wagner AdamSee remarks | 103,987 |
| Kenost Jared MatthewSee Remarks | 42,974 |
Questions about CRON
What does Cronos Group Inc. do?
Cronos Group Inc. is a company in the Health care sector, listed on NASDAQ as CRON. Its shares trade on NASDAQ under the ticker CRON.
What is Cronos Group Inc.'s net worth?
Cronos Group Inc. has a market value (market cap) of $1.3B at the latest share price, and shareholders' equity of $1.1B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Cronos Group Inc. profitable?
Yes. Over the twelve months to September 30, 2026 it reported net income of $57.8M on revenue of $271.9M, a net margin of 21.3%.
How much revenue does Cronos Group Inc. make?
Over the twelve months to September 30, 2026 Cronos Group Inc. reported revenue of $271.9M. That is 54.3% more than a year earlier.
When did Cronos Group Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 5, 2026. It covers the period to September 30, 2026.
When is Cronos Group Inc.'s next earnings report?
Cronos Group Inc.'s next report is expected around February 25, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare CRON with
Follow CRON
Get an email when Cronos Group Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Cronos Group Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.